Richard S. Lindahl
EVP, Chief Financial Officer · Emergent BioSolutions Inc.
Individual
- 2024
- Jun 10, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard S. Lindahl files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald W. Degolyer - $444K in EBS purchases and sales in the last 12 months
- Sujata Tyagi Dayal - $201K in EBS purchases and sales in the last 12 months
- Kathryn C. Zoon - $144K in EBS purchases and sales in the last 12 months
- Keith Katkin - $128K in EBS purchases and sales in the last 12 months
- Paul Anthony Williams - $79K in EBS purchases and sales in the last 12 months
- Neil Lerner - $21K in CMPX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard S. Lindahl?
Richard S. Lindahl is a corporate insider, tracked as EVP, Chief Financial Officer of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Richard S. Lindahl last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 9 filings going back to 2024.
